Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02740634 · ClinicalTrials.gov registry record · NA

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

A NA study of Alzheimer Disease and Alzheimer Disease, Early Onset, sponsored by Mayo Clinic.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT02740634 is a NA study of Alzheimer Disease and Alzheimer Disease, Early Onset that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02740634, a NA study of Alzheimer Disease and Alzheimer Disease, Early Onset, is active but no longer recruiting, sponsored by Mayo Clinic.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This is a neuroimaging study designed to learn more about amyloid and tau burden in the brain of patients with typical and atypical Alzheimer's Disease and how burden may change over a one year period.

Conditions Studied

Alzheimer Disease Alzheimer Disease, Early Onset Amnestic Mild Cognitive Disorder Logopenic Progressive Aphasia (LPA) Atypical Alzheimer's Disease Amnestic Symptoms Posterior Cortical Atrophy (PCA) Amnestic Disorder

Interventions

  • DRUG F-18 AV 1451
  • DRUG C-11 PiB

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2016-05
Est. Completion 2026-03
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02740634

The ClinicalTrials.gov registry entry for NCT02740634 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which F-18 AV 1451 is the first listed.

NCT02740634 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02740634 about?

NCT02740634 is a clinical study titled "Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study". This is a neuroimaging study designed to learn more about amyloid and tau burden in the brain of patients with typical and atypical Alzheimer's Disease and how burden may change over a one year period.

What is the current status of trial NCT02740634?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2016-05. Estimated completion is 2026-03.

What conditions does trial NCT02740634 study?

This clinical trial studies the following conditions: Alzheimer Disease, Alzheimer Disease, Early Onset, Amnestic Mild Cognitive Disorder, Logopenic Progressive Aphasia (LPA), Atypical Alzheimer's Disease.

What interventions are being tested in trial NCT02740634?

The interventions under investigation include: F-18 AV 1451 (DRUG), C-11 PiB (DRUG).

Who is sponsoring clinical trial NCT02740634?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02740634 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Alzheimer Disease, Early Onset

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.